Videos

Treating patients with lung cancer by identifying specific biomarkers to use the correct combination therapy and what it means for a biomarker to be actionable.

Knowledge and open communication are key to creating a competent cancer care team and ensuring better outcomes.

Shared insight on the importance of support networks, both medical and personal, in the treatment journey of multiple myeloma.

Taking her own experience with multiple myeloma into account, Marcella shares how she learned to live with the disease by practicing good health and communication habits.

The CURE® Poetry Contest winners explain what inspired each of their poems, from the death of a friend and oncologist who treated one survivor’s cancer to the emotional experience of losing hair during treatment.

Patients and caregivers of those with kidney cancer can become active members in their care by staying up to date on the latest treatments and medical advances.

View the full CURE® Educated Patient® Webinar: Treatment and Care for Thyroid Cancer on demand.

A discussion of how patients and physicians can work together to decide on the best individualized treatment option for multiple myeloma.

Kenneth Shain, M.D., Ph.D., and Marcella reflect on how she didn’t tolerate her second line of therapy for multiple myeloma well and moved to a novel treatment regimen thereafter.

Retired FDNY firefighter and lung cancer survivor Jerry Sanford spoke about how he helped the rescue efforts following the Sept. 11 terrorist attacks in New York City.

Kenneth Shain, M.D., Ph.D., discusses the use of maintenance therapy and observation in multiple myeloma as Marcella shares her own experience with multiple myeloma remission.

Marcella, accompanied by Kenneth Shain, M.D., Ph.D., shares her experience in preparing for autologous stem cell transplant to treat her multiple myeloma.

Circulating tumor DNA found in blood plasma may help predict if the likelihood of relapse for patients with large B-cell lymphoma, according to recent research.

Kenneth Shain, M.D., Ph.D., and Marcella reflect on the first line of therapy she received for multiple myeloma in light of her response and reaction to certain treatments.

Olympic triathlete Kevin McDowell explains how certain aspects of surviving cancer and training for the Olympics became intertwined throughout his journey.

A brief discussion of how Marcella reacted to her diagnosis of multiple myeloma and the importance of support networks for patients.

View the full CURE Educated Patient MPN Summit on demand.

CURE spoke with Maimah Karmo, founder and CEO of the Tigerlily Foundation, about support after a breast cancer diagnosis.

CURE spoke with Maimah Karmo, founder and CEO of the Tigerlily Foundation, about aspects outside of breast cancer treatment, like financial toxicity, psychosocial effects and more.

CURE spoke with Maimah Karmo, founder and CEO of the Tigerlily Foundation, about disparities in breast cancer care, and how they are being addressed.

On behalf of TigerLilly Foundation, CURE spoke with Dr. Andrea Phillips about clinical trials in breast cancer.

On behalf of TigerLilly Foundation, CURE spoke with Dr. Angelique Richardson, from UCSD Health, about HER2-positive breast cancer.

Marcella shares how she met her diagnosis of multiple myeloma as Kenneth Shain, M.D., Ph.D., considers her experience in relation to other patients with multiple myeloma.

View the full CURE® Educated Patient® Webinar: Individualized Treatment for Small Cell Lung Cancer on demand.

View the full CURE® Educated Patient® Webinar: Stomach Cancer 101 Series: Part II - Treatment on demand.

Combining PI3 kinase inhibitors with BTK inhibitors can mitigate side effects traditionally seen with PI3 kinase inhibitors, according to recent research.

Latasha Jordan and Aditya Bardia, M.D., MPH, share advice for patients and caregivers on the importance of a positive outlook and attitude when living with triple-negative breast cancer.

A triple-negative breast cancer (TNBC) survivor, Latasha Jordan, considers the positive impact her support network has had on her treatment; and Aditya Bardia, M.D., MPH, emphasizes the importance of social support systems for patients with TNBC.

Latasha Jordan discusses her experience in a clinical trial with sacituzumab govitecan and comments on the side effects she experienced as well as the overall impact on her quality of life.

An expert oncologist highlights the importance of discussing clinical trial options with patients and comments on the recent FDA approval of sacituzumab govitecan in triple-negative breast cancer based on the ASCENT 3 trial.